DOI QR코드

DOI QR Code

Defining Coronary Artery Perforation with Ultrasound Contrast Agent

  • Youn, Young Jin (Division of Cardiology, Department of Internal Medicine, Wonju College of Medicine, Yonsei University) ;
  • Khalid, Salman (Division of Cardiovascular Medicine, Calhoun Cardiovascular Center, University of Connecticut School of Medicine) ;
  • Azrin, Michael (Division of Cardiovascular Medicine, Calhoun Cardiovascular Center, University of Connecticut School of Medicine) ;
  • Lee, Juyong (Division of Cardiovascular Medicine, Calhoun Cardiovascular Center, University of Connecticut School of Medicine)
  • Received : 2018.05.25
  • Accepted : 2018.07.17
  • Published : 2018.11.30

Abstract

Keywords

References

  1. Ellis SG, Ajluni S, Arnold AZ, et al. Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation 1994;90:2725-30. https://doi.org/10.1161/01.CIR.90.6.2725
  2. Oreglia JA, Bruschi G, Klugmann S. Percutaneous treatment of iatrogenic left-anterior descending artery to right ventricle fistula. Catheter Cardiovasc Interv 2010;76:975-7. https://doi.org/10.1002/ccd.22551
  3. Main ML, Hibberd MG, Ryan A, Lowe TJ, Miller P, Bhat G. Acute mortality in critically ill patients undergoing echocardiography with or without an ultrasound contrast agent. JACC Cardiovasc Imaging 2014;7:40-8. https://doi.org/10.1016/j.jcmg.2013.08.012
  4. Muskula PR, Main ML. Safety with echocardiographic contrast agents. Circ Cardiovasc Imaging 2017;10:e005459.